Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RGEN
REPLIGEN CORPORATION
NASDAQ
$169.61
▼ DOWN 1.93% (-3.33)

KEY STATISTICS

Market Cap$9.55 B
52w High$188.73
52w Low$100.99
Dividend Yield—
Frequency—
P/E94.23
Volume1.33M
Shares Out.56.44M

COMPANY

LEADERSHIP

Olivier Loeillot
CHIEF EXECUTIVE
Olivier Loeillot

COMPENSATION 2026

Salary$860,000
Stock Awards$3,374,853
Incentive Plan Pay$774,000
All Other Comp.$10,292
Total$6,114,771

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 29, 1986
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
2,000

PRICE TARGET

Target High$160.00
Target Low$142.00
Target Median$152.50
Target Consensus$152.00

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$206.79M
NOV
3
TUE

PRICE

$169.61 ▼ DOWN 1.93% (−$3.33)
$168$170$173$1759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM169.61

About Repligen Corporation

https://www.repligen.com ↗

Repligen Corporation develops and sells bioprocessing technologies, including chromatography, filtration, and analytics products, for biopharmaceutical manufacturing worldwide.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT REPLIGEN CORPORATION IS KNOWN FOR

AVIPure® HiPer™ AAV9, AVIPure® HiPer™ AAV8, and HiPer™ QA anion exchange resins
AVIPure® HiPer™ AAV9, AVIPure® HiPer™ AAV8, and HiPer™ QA anion exchange resins

Launched in December 2025, Repligen's three high-performance chromatography resins enhance viral vector manufacturing for gene therapies by accelerating development, improving stability, and optimizing production economics.

COMPETITORS

COMPETITOR
A COMPARE
AVTR COMPARE
DHR COMPARE
TECH COMPARE
TMO COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$188.77M $197.73M ▲$194.21M ▼$204.09M ▲
Royalty$39K — $44K ▲$43K ▼

Revenue by Geography

MapREGIONQ1-2018Q2-2018Q3-2018
North America$20.24M $22.48M ▲$24.06M ▲
Europe$19.4M $19.58M ▲$19.33M ▼
Asia And Australia— $5.62M $6.08M ▲
Asia Pacific$4.95M — —
All Other$243K $55K ▼$62K ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
228
LISTED HERE
26
RANKED BY POSITION SIZE
XMC.TO
0.26% · 1.9M
VTS.AX
0.01% · 1.7M
FBT
3.65% · 627.7K
MDY
0.25% · 389.1K
DFAS
0.19% · 176.0K
SCHM
0.17% · 146.8K
PBE
3.38% · 95.0K
CSMD
3.36% · 92.2K
FWD
0.47% · 87.6K
FMTM
3.23% · 52.8K
TMSL
0.26% · 45.9K
TFGZ
3.32% · 42.2K
FRTY
4.31% · 36.8K
JHMM
0.11% · 36.5K
FSMD
0.23% · 31.6K
BBMC
0.20% · 24.1K
SMOT
0.90% · 16.4K
WSCSRI.SW
0.36% · 16.4K
GSC
0.88% · 13.6K
AEJ.L
0.25% · 12.5K
AFTY
1.30% · 12.2K
BKMC
0.22% · 8.6K
IQSM
0.37% · 7.4K
TPSC
0.25% · 5.5K
ETHO
0.42% · 4.8K
EZM
0.08% · 4.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
74.39%
HOLDERS
746
TOP 12 OF 746 · RANKED BY POSITION SIZE
Blackrock Inc.
7.6M sh · $954.08M
Blackrock, Inc.
6.6M sh · $1.08B
Vanguard Group Inc
5.0M sh · $674.26M
Price T Rowe Associates Inc /Md/
4.9M sh · $574.74M
Fmr LLC
3.3M sh · $453.89M
Blackrock Fund Advisors
3.1M sh · $94.81M
United Capital Financial Advisers, LLC
2.8M sh · $380.76M
Maverick Capital Ltd
2.0M sh · $270.77M
State Street Corp
1.8M sh · $240.81M
Citadel Advisors LLC
1.7M sh · $225.2M
Massachusetts Financial Services Co /Ma/
1.6M sh · $220.61M
Wasatch Advisors LP
1.6M sh · $216.97M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity3
Return On Assets3
Debt To Equity2
Price To Earnings1
Price To Book2
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Lisa McClain
Lisa McClain
Purchase
2025-07-22
 Josh Gottheimer
Josh Gottheimer
Purchase
2022-05-05
 Ro Khanna
Ro Khanna
Sale
2022-04-11

INSIDER TRADES

★
OFFICER: CHIEF ACCOUNTING OFFICER
Hughes Violetta
Purchase · 2.5K shares
2026-03-05
★
OFFICER: CHIEF ACCOUNTING OFFICER
Hughes Violetta
Sale · 277 shares
2026-09-01
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Loeillot Olivier
Purchase · 5.4K shares
2026-08-20
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Loeillot Olivier
Sale · 5.4K shares
2026-08-20

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
OVERWEIGHT 3
HOLD 2
OUTPERFORM 1
10 GRADES IN THE LAST 12 MONTHS
Wells Fargo OVERWEIGHT JP Morgan OVERWEIGHT Benchmark BUY Evercore ISI Group OUTPERFORM HSBC BUY Barclays OVERWEIGHT Canaccord Genuity HOLD HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
CRL$289.61COMPARE
BAX$25.45COMPARE
DVA$182.13COMPARE
GMED$78.91COMPARE
BIO$387.75COMPARE
AVTR$14.94COMPARE
ATR$128.04COMPARE
STVN$20.49COMPARE